ASCO GU 2019
Seattle Cancer Care Alliance Physicians to Present their Research at Genitourinary Cancers Symposium
February 11, 2020
ASCO GU 2019: Phase II Trial of Pembrolizumab for Patients with High-Risk Non-Muscle Invasive Bladder Cancer Unresponsive to BCG
February 28, 2019
ASCO GU 2019: Results from KEYNOTE-427 Cohort B: First-line Pembrolizumab Monotherapy for Advanced Non-Clear Cell Renal Cell Carcinoma
February 23, 2019
ASCO GU 2019: Outcomes of Patients with Metastatic Clear Cell RCC Treated with Second Line VEGFR-TKI After First Line Immune Checkpoint Inhibitor
February 23, 2019
ASCO GU 2019: Pembrolizumab in Men With Heavily Treated Metastatic Castration-Resistant Prostate Cancer
February 22, 2019
ASCO GU 2019: Questions and Lessons Moving Forward from CARMENA: Which Treatment First? Surgeon’s Perspective
February 22, 2019
ASCO GU 2019: Questions and Lessons Moving Forward from CARMENA: Which Treatment First? Medical Oncologist’s Perspective
February 21, 2019
ASCO GU 2019: Informing the Decision Using Data Science
February 21, 2019
ASCO GU 2019: Quality Metrics in Kidney Cancer Care
February 21, 2019
ASCO GU 2019: Outcomes for Avelumab Plus Axitinib versus Sunitinib in Advanced RCC - JAVELIN Renal 101: A Subgroup Analysis
February 21, 2019
ASCO GU 2019: Kidney Cancer Case-Based Panel: Localized Disease
February 21, 2019